These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32670595)
1. Saudi Arabia, pharmacists and COVID-19 pandemic. Ahmad A; Alkharfy KM; Alrabiah Z; Alhossan A J Pharm Policy Pract; 2020; 13():41. PubMed ID: 32670595 [TBL] [Abstract][Full Text] [Related]
2. Splitting Teams at a Hospital Pharmaceutical Care Services during COVID-19 Pandemic: A Tertiary Hospital Experience in Saudi Arabia. Bakhsh HT; Makki H J Microsc Ultrastruct; 2020; 8(4):152-155. PubMed ID: 33623739 [TBL] [Abstract][Full Text] [Related]
3. Pharmacists' satisfaction with their involvement in the management of COVID-19 patients in Saudi Arabia. Assiri A; Iqbal MJ; Gramish J; Assiri A; Meraya A; Alhossan A; Khobrani M Saudi Pharm J; 2021 Jan; 29(1):85-90. PubMed ID: 33437172 [TBL] [Abstract][Full Text] [Related]
4. Patient satisfaction with pharmaceutical care services for chronic diseases and their medication adherence during COVID-19 in Saudi Arabia. Lucca JM; Kurdi S; Albaqshi B; Joseph R Int J Pharm Pract; 2022 May; 30(2):136-142. PubMed ID: 35294010 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis. Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964 [TBL] [Abstract][Full Text] [Related]
6. Investigating healthcare practitioners' attitudes towards the COVID-19 outbreak in Saudi Arabia: A general qualitative framework for managing the pandemic. Alanezi F; Aljahdali A; Alyousef SM; Alshaikh W; Mushcab H; AlThani B; Alghamedy F; Alotaibi H; Alrajhi S; Alabbadi D; Alanzi TM Inform Med Unlocked; 2021; 22():100491. PubMed ID: 33319030 [TBL] [Abstract][Full Text] [Related]
7. Community pharmacist's preparedness to provide patient-centred care in Saudi Arabia. Rasheed MK; Hasan SS; Altowayan WM; Farooqui M; Ud-Din Babar Z Saudi Pharm J; 2023 Jun; 31(6):801-807. PubMed ID: 37228322 [TBL] [Abstract][Full Text] [Related]
8. Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis. Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B Saudi Pharm J; 2020 May; 28(5):529-537. PubMed ID: 32435133 [TBL] [Abstract][Full Text] [Related]
9. Perceived barriers and facilitators to uptake of non-traditional roles by pharmacists in Saudi Arabia and implications for COVID-19 pandemic and beyond: a qualitative study using Theoretical Domain Framework. Mohammed E; Khanal S; Jalal Z; Cheema E; Abutaleb MH; Paudyal V J Pharm Policy Pract; 2021 Feb; 14(1):25. PubMed ID: 33627172 [TBL] [Abstract][Full Text] [Related]
10. Cross-sectional study to evaluate burnout among pharmacy staff in Saudi Arabia during COVID-19 pandemic. Aljuffali LA; Alshabanah MO; Almalag HM Saudi Pharm J; 2022 Apr; 30(4):440-453. PubMed ID: 35125906 [TBL] [Abstract][Full Text] [Related]
11. Over-the-counter sale of antibiotics during COVID-19 outbreak by community pharmacies in Saudi Arabia: a simulated client study. Khojah HMJ BMC Health Serv Res; 2022 Jan; 22(1):123. PubMed ID: 35093049 [TBL] [Abstract][Full Text] [Related]
12. Improving medication dispensing and counselling for patients with vision impairment: a qualitative study of pharmacist-reported barriers and facilitators. Kentab BY; Barry HE; Al-Aqeel SA; Hughes CM BMC Health Serv Res; 2024 Apr; 24(1):534. PubMed ID: 38671437 [TBL] [Abstract][Full Text] [Related]
13. Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations. Song Z; Hu Y; Ren Z; Wang G; Liu S; Zheng S; Yang L; Zhao R Front Public Health; 2021; 9():758325. PubMed ID: 35087781 [No Abstract] [Full Text] [Related]
14. Evaluation of Outreach of Community Pharmacists in Public Health Services in Al-Jouf Region of Saudi Arabia: Findings and Implications. Alzarea AI; Khan YH; Alanazi AS; Alotaibi NH; Alzarea SI; Almalki ZS; Alqahtani SS; Mallhi TH Healthcare (Basel); 2023 Aug; 11(16):. PubMed ID: 37628497 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Resistance Awareness, Antibiotics Prescription Errors and Dispensing Patterns by Community Pharmacists in Saudi Arabia. Alajmi AM; Alamoudi AA; Halwani AA; Almangour TA; Almozain NH; Al-Jedai A; Tawfik EA J Infect Public Health; 2023 Jan; 16(1):34-41. PubMed ID: 36459709 [TBL] [Abstract][Full Text] [Related]
16. Patients Self-Reporting of Utilizing Teledental Services During the COVID-19 Pandemic in Saudi Arabia. Bugis BA J Patient Exp; 2022; 9():23743735221112209. PubMed ID: 35846242 [No Abstract] [Full Text] [Related]
17. Patients' perception, views and satisfaction with pharmacists' role as health care provider in community pharmacy setting at Riyadh, Saudi Arabia. Al-Arifi MN Saudi Pharm J; 2012 Oct; 20(4):323-30. PubMed ID: 23960807 [TBL] [Abstract][Full Text] [Related]
18. Strategic initiatives to maintain pharmaceutical care and clinical pharmacists sufficiency in Saudi Arabia. Albekairy AM; Khalidi N; Alkatheri AM; Althiab K; Alharbi S; Aldekhael S; Qandil AM; Alknawy B SAGE Open Med; 2015; 3():2050312115594816. PubMed ID: 26770792 [TBL] [Abstract][Full Text] [Related]
19. Do pharmacists counsel customers about the effects of sedating antihistamines on driving skills? A survey of community pharmacies in Saudi Arabia. Khojah HM J Int Med Res; 2019 May; 47(5):2018-2025. PubMed ID: 30885078 [TBL] [Abstract][Full Text] [Related]
20. Pharmacists' Prescribing in Saudi Arabia: Cross-Sectional Study Describing Current Practices and Future Perspectives. Ajabnoor AM; Cooper RJ Pharmacy (Basel); 2020 Sep; 8(3):. PubMed ID: 32887315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]